Opioid Crisis Resources

According to the Centers for Disease Control and Prevention (CDC), 91 people die every day from an opioid overdose. AANA is committed to taking action toward solutions to the opioid epidemic, with CRNAs playing a key role in the process.

AANA has developed and compiled resources and tools for patients and healthcare providers to support meaningful decision-making regarding acute and chronic pain management, opioid safety, substance use disorder, and more. Use the buttons below to navigate AANA's resources.

Breaking News and Alerts

Statement on the FDA's benefit-risk framework for evaluating opioid analgesics, June 20, 2019

Statement from FDA Commissioner Scott Gottlieb, M.D. on the agency’s 2019 policy and regulatory agenda for continued action to forcefully address the tragic epidemic of opioid abuse, February 26, 2019

FDA in Brief: FDA finalizes new policy to encourage widespread innovation and development of new buprenorphine treatments for opioid use disorder, February 7, 2019

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s approval of Dsuvia and the FDA’s future consideration of new opioids, November 2, 2018

Statement by FDA Commissioner Scott Gottlieb, M.D., on the agency’s ongoing work to forcefully address the opioid crisis, August 29, 2018

FDA takes action against 21 websites marketing unapproved opioids as part of agency’s effort to target illegal online sales, August 28, 2018

FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder, August 6, 2018

CRNAs and MAT

Opioid Crisis Data

Opioid Safety and Advocacy Toolkit

Opioid Safety (Providers)

Substance Use Disorder (Patients and Providers)

Substance Use Disorder Facility Policy

Managing Pain (Patients)

Getting Help (CRNAs and SRNAs)

Advocacy Comment Letters

Prescription Medicine Disposal